Suppr超能文献

芳香化酶抑制剂δ1-睾酮内酯对多囊卵巢疾病中促性腺激素释放及类固醇代谢的影响。

The effects of the aromatase inhibitor delta 1-testolactone on gonadotropin release and steroid metabolism in polycystic ovarian disease.

作者信息

Dunaif A, Longcope C, Canick J, Badger T, Crowley W F

出版信息

J Clin Endocrinol Metab. 1985 Apr;60(4):773-80. doi: 10.1210/jcem-60-4-773.

Abstract

This study was designed to examine the importance of aromatization in the gonadotropin secretory dynamics of polycystic ovarian disease (PCOD) by using the aromatase inhibitor delta 1 testolactone (TL) as a probe and to determine the effects of TL on steroid metabolism in vivo and in vitro. The pulsatile patterns of gonadotropin secretion and peripheral steroid levels were studied in eight women with PCOD before and during TL administration. There was a significant fall in peripheral estrone (E1) levels, a rise in peripheral androstenedione levels, and an increase in the androstenedione/E1 ratio during TL administration in these women. Isotopic determinations of androgen and estrogen production and metabolism before and during TL administration in two women confirmed a 90-95% decrease in the overall rate of aromatization. One patient also had an increase in the production and clearance rates of estradiol and E1 during TL administration, suggesting resistance to TL of the ovarian aromatase enzyme system. There were significant increases in both mean LH pulse amplitude [1.2 +/- 0.3 (SE) mIU/ml LER-907 before vs. 1.7 +/- 0.3 mIU/ml LER-907 during TL, P less than 0.05, paired t test] and frequency per 6 h (median: 3 before vs. 4 during TL, P less than 0.05, Wilcoxon signed rank test). Mean levels of LH and FSH did not, however, change significantly during TL administration. TL maximally inhibited neonatal rat hypothalamic aromatase in vitro at concentrations of 200 microM, a level theoretically obtainable during pharmacological therapy. These data suggest that: 1) in humans TL is a potent inhibitor of peripheral but not ovarian aromatase, and of hypothalamic aromatase in rats; 2) TL administration increases LH pulse amplitude and frequency in PCOD, either directly via hypothalamic aromatase inhibition, or indirectly by alterations in gonadal steroid metabolism; and 3) because of the multiple potential actions of TL, its usefulness as a probe in studies of gonadotropin secretion in PCOD is limited.

摘要

本研究旨在通过使用芳香化酶抑制剂δ1-睾内酯(TL)作为探针,研究芳香化作用在多囊卵巢疾病(PCOD)促性腺激素分泌动力学中的重要性,并确定TL对体内外类固醇代谢的影响。在8名PCOD女性患者服用TL之前和期间,研究了促性腺激素分泌的脉冲模式和外周类固醇水平。在这些女性服用TL期间,外周雌酮(E1)水平显著下降,外周雄烯二酮水平升高,雄烯二酮/E1比值增加。对两名女性在服用TL之前和期间雄激素和雌激素生成及代谢的同位素测定证实,总体芳香化率降低了90%-95%。一名患者在服用TL期间雌二醇和E1的生成及清除率也有所增加,提示卵巢芳香化酶系统对TL有抵抗作用。平均LH脉冲幅度[服用TL前为1.2±0.3(SE)mIU/ml LER-907,服用TL期间为1.7±0.3 mIU/ml LER-907,P<0.05,配对t检验]和每6小时的频率(中位数:服用TL前为3次,服用TL期间为4次,P<0.05,Wilcoxon符号秩检验)均显著增加。然而,服用TL期间LH和FSH的平均水平没有显著变化。TL在体外以200 microM的浓度可最大程度抑制新生大鼠下丘脑芳香化酶,这是药物治疗期间理论上可达到的水平。这些数据表明:1)在人类中,TL是外周而非卵巢芳香化酶以及大鼠下丘脑芳香化酶的有效抑制剂;2)服用TL可增加PCOD患者的LH脉冲幅度和频率,可能是直接通过抑制下丘脑芳香化酶,或间接通过性腺类固醇代谢的改变;3)由于TL具有多种潜在作用,其作为PCOD促性腺激素分泌研究探针的实用性有限。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验